Ambu A/S (AMBBY)
- Previous Close
18.50 - Open
18.50 - Bid 17.67 x 40000
- Ask 18.91 x 46000
- Day's Range
18.37 - 18.63 - 52 Week Range
9.45 - 22.65 - Volume
1,318 - Avg. Volume
171 - Market Cap (intraday)
4.945B - Beta (5Y Monthly) 0.77
- PE Ratio (TTM)
73.48 - EPS (TTM)
0.25 - Earnings Date Nov 5, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date Dec 15, 2021
- 1y Target Est
--
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. The company was founded in 1937 and is headquartered in Ballerup, Denmark.
www.ambu.comRecent News: AMBBY
View MorePerformance Overview: AMBBY
Trailing total returns as of 10/17/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AMBBY
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AMBBY
View MoreValuation Measures
Market Cap
4.99B
Enterprise Value
5.00B
Trailing P/E
74.35
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.35
Price/Book (mrq)
5.82
Enterprise Value/Revenue
6.46
Enterprise Value/EBITDA
35.73
Financial Highlights
Profitability and Income Statement
Profit Margin
8.55%
Return on Assets (ttm)
5.27%
Return on Equity (ttm)
8.19%
Revenue (ttm)
5.26B
Net Income Avi to Common (ttm)
450M
Diluted EPS (ttm)
0.25
Balance Sheet and Cash Flow
Total Cash (mrq)
534M
Total Debt/Equity (mrq)
10.64%
Levered Free Cash Flow (ttm)
440.88M
Company Insights: AMBBY
AMBBY does not have Company Insights